Ikarian Capital as of March 31, 2020
Portfolio Holdings for Ikarian Capital
Ikarian Capital holds 115 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 23.3 | $309M | 1.2M | 257.75 | |
| Acceleron Pharma | 5.2 | $69M | 766k | 89.87 | |
| iShares Barclays 20+ Yr Treas.Bond (TLT) | 5.0 | $66M | 400k | 164.97 | |
| Regeneron Pharmaceuticals (REGN) | 4.8 | $64M | 130k | 488.29 | |
| Biogen Idec (BIIB) | 3.4 | $46M | 144k | 316.98 | |
| Alnylam Pharmaceuticals (ALNY) | 3.0 | $40M | 367k | 108.85 | |
| SPDR S&P Biotech (XBI) | 2.9 | $39M | 500k | 77.44 | |
| Zogenix | 2.8 | $37M | 1.5M | 24.73 | |
| Argenx Se (ARGX) | 2.6 | $35M | 267k | 131.73 | |
| Axsome Therapeutics (AXSM) | 2.3 | $31M | 525k | 58.83 | |
| Invesco Qqq Trust Series 1 (QQQ) | 2.2 | $30M | 550k | 53.73 | |
| Myokardia | 1.9 | $25M | 533k | 46.88 | |
| iShares Russell 2000 Index (IWM) | 1.4 | $19M | 165k | 114.49 | |
| Gilead Sciences (GILD) | 1.4 | $19M | 250k | 74.76 | |
| Reata Pharmaceuticals Inc Cl A | 1.4 | $18M | 125k | 144.34 | |
| Alexion Pharmaceuticals | 1.4 | $18M | 200k | 89.79 | |
| Bioxcel Therapeutics (BTAI) | 1.3 | $18M | 797k | 22.35 | |
| ACADIA Pharmaceuticals (ACAD) | 1.2 | $17M | 390k | 42.25 | |
| Ligand Pharmaceuticals In (LGND) | 1.1 | $15M | 200k | 72.72 | |
| Intercept Pharmaceuticals In | 1.1 | $14M | 222k | 62.96 | |
| Verastem | 1.0 | $14M | 5.3M | 2.64 | |
| Immunovant (IMVT) | 1.0 | $13M | 843k | 15.57 | |
| Biohaven Pharmaceutical Holding | 0.9 | $12M | 350k | 34.03 | |
| Mirati Therapeutics | 0.9 | $11M | 149k | 76.87 | |
| Abbvie (ABBV) | 0.9 | $11M | 150k | 76.19 | |
| Karyopharm Therapeutics (KPTI) | 0.8 | $11M | 588k | 19.21 | |
| Cytokinetics (CYTK) | 0.8 | $10M | 884k | 11.79 | |
| Artara Therapeutics | 0.8 | $10M | 451k | 23.00 | |
| Adverum Biotechnologies | 0.8 | $10M | 224k | 45.48 | |
| Sarepta Therapeutics (SRPT) | 0.8 | $10M | 103k | 97.82 | |
| Aduro Biotech | 0.7 | $10M | 3.6M | 2.74 | |
| Fibrogen (FGEN) | 0.7 | $9.7M | 280k | 34.75 | |
| Sage Therapeutics (SAGE) | 0.7 | $9.7M | 337k | 28.72 | |
| Neurocrine Biosciences (NBIX) | 0.7 | $8.7M | 100k | 86.55 | |
| Ardelyx (ARDX) | 0.6 | $8.3M | 1.5M | 5.69 | |
| Scpharmaceuticals (SCPH) | 0.6 | $7.9M | 1.1M | 7.40 | |
| Ocular Therapeutix (OCUL) | 0.6 | $7.7M | 1.6M | 4.95 | |
| Crispr Therapeutics (CRSP) | 0.6 | $7.6M | 179k | 42.41 | |
| Insmed (INSM) | 0.6 | $7.6M | 473k | 16.03 | |
| Chiasma | 0.6 | $7.6M | 2.1M | 3.65 | |
| Kura Oncology (KURA) | 0.6 | $7.6M | 760k | 9.95 | |
| Cara Therapeutics (CARA) | 0.6 | $7.6M | 572k | 13.21 | |
| Clovis Oncology | 0.6 | $7.5M | 1.2M | 6.36 | |
| Millendo Therapeutics | 0.6 | $7.4M | 1.4M | 5.28 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $7.2M | 947k | 7.65 | |
| Galapagos Nv- (GLPG) | 0.5 | $6.9M | 35k | 195.91 | |
| Blueprint Medicines (BPMC) | 0.5 | $6.8M | 116k | 58.48 | |
| Flamel Technologies Sa (AVDL) | 0.5 | $6.6M | 832k | 7.94 | |
| Strongbridge Bioph shs usd | 0.5 | $6.4M | 3.4M | 1.89 | |
| Chemocentryx | 0.5 | $6.0M | 150k | 40.18 | |
| Cel Sci (CVM) | 0.4 | $5.8M | 500k | 11.54 | |
| Kiniksa Pharmaceuticals (KNSA) | 0.4 | $5.6M | 359k | 15.48 | |
| Kadmon Hldgs | 0.4 | $5.5M | 1.3M | 4.19 | |
| Ultragenyx Pharmaceutical (RARE) | 0.4 | $5.1M | 114k | 44.43 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $5.0M | 444k | 11.34 | |
| Aurinia Pharmaceuticals (AUPH) | 0.3 | $4.6M | 319k | 14.51 | |
| Global Blood Therapeutics In | 0.3 | $4.6M | 90k | 51.09 | |
| Assembly Biosciences | 0.3 | $4.6M | 308k | 14.83 | |
| Minerva Neurosciences | 0.3 | $4.4M | 724k | 6.02 | |
| Kala Pharmaceuticals | 0.3 | $4.3M | 494k | 8.79 | |
| Tricida | 0.3 | $4.0M | 180k | 22.00 | |
| Intra Cellular Therapies (ITCI) | 0.3 | $3.8M | 249k | 15.37 | |
| Ascendis Pharma A S (ASND) | 0.3 | $3.8M | 70k | 53.73 | |
| Rts/bristol-myers Squibb Compa | 0.3 | $3.6M | 950k | 3.80 | |
| Bluebird Bio (BLUE) | 0.3 | $3.5M | 77k | 45.96 | |
| Cymabay Therapeutics | 0.3 | $3.5M | 2.4M | 1.48 | |
| Myovant Sciences | 0.3 | $3.4M | 450k | 7.55 | |
| Otonomy | 0.2 | $3.3M | 1.7M | 1.97 | |
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $2.7M | 40k | 66.77 | |
| Allakos (ALLK) | 0.2 | $2.7M | 60k | 44.50 | |
| Rigel Pharmaceuticals (RIGL) | 0.2 | $2.6M | 1.7M | 1.56 | |
| Bridgebio Pharma (BBIO) | 0.2 | $2.5M | 88k | 29.00 | |
| Solid Biosciences | 0.2 | $2.4M | 989k | 2.39 | |
| Intellia Therapeutics (NTLA) | 0.2 | $2.3M | 185k | 12.23 | |
| Arvinas Ord (ARVN) | 0.2 | $2.3M | 56k | 40.30 | |
| Fate Therapeutics (FATE) | 0.2 | $2.2M | 100k | 22.22 | |
| Casi Pharmaceuticalsinc Com Stk | 0.2 | $2.1M | 1.0M | 2.04 | |
| Macrogenics (MGNX) | 0.2 | $2.1M | 360k | 5.82 | |
| Relmada Therapeutics (RLMD) | 0.1 | $1.9M | 55k | 34.11 | |
| Inovio Pharmaceuticals | 0.1 | $1.9M | 250k | 7.44 | |
| Adma Biologics (ADMA) | 0.1 | $1.8M | 630k | 2.88 | |
| Applied Genetic Technol Corp C | 0.1 | $1.8M | 546k | 3.28 | |
| Albireo Pharma | 0.1 | $1.6M | 101k | 16.37 | |
| Immunomedics | 0.1 | $1.6M | 116k | 13.48 | |
| Nextcure (NXTC) | 0.1 | $1.5M | 41k | 37.08 | |
| Cerecor | 0.1 | $1.4M | 564k | 2.48 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $1.4M | 52k | 26.78 | |
| Coherus Biosciences (CHRS) | 0.1 | $1.4M | 84k | 16.22 | |
| Aptinyx | 0.1 | $1.3M | 591k | 2.16 | |
| Cassava Sciences (SAVA) | 0.1 | $1.2M | 300k | 4.11 | |
| Cortexyme (QNCX) | 0.1 | $1.1M | 25k | 45.60 | |
| Ovid Therapeutics (OVID) | 0.1 | $1.1M | 378k | 2.98 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $1.1M | 158k | 7.06 | |
| Dbv Technologies S A (DBVT) | 0.1 | $1.1M | 281k | 3.92 | |
| Inflarx Nv (IFRX) | 0.1 | $1.0M | 263k | 3.82 | |
| Mustang Bio | 0.1 | $955k | 357k | 2.68 | |
| Bellus Health | 0.1 | $891k | 64k | 13.98 | |
| Icad (ICAD) | 0.1 | $786k | 107k | 7.34 | |
| Viking Therapeutics (VKTX) | 0.0 | $590k | 126k | 4.68 | |
| Pfenex | 0.0 | $566k | 64k | 8.81 | |
| Kodiak Sciences (KOD) | 0.0 | $563k | 12k | 47.71 | |
| Progenics Pharmaceuticals | 0.0 | $497k | 131k | 3.80 | |
| Puma Biotechnology (PBYI) | 0.0 | $463k | 55k | 8.43 | |
| Axovant Gene The | 0.0 | $461k | 189k | 2.44 | |
| Baudax Bio | 0.0 | $434k | 175k | 2.48 | |
| Mallinckrodt Pub | 0.0 | $385k | 194k | 1.98 | |
| Chimerix (CMRX) | 0.0 | $300k | 208k | 1.44 | |
| Cellectis S A (CLLS) | 0.0 | $285k | 31k | 9.21 | |
| Dicerna Pharmaceuticals | 0.0 | $285k | 16k | 18.39 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.0 | $207k | 7.2k | 28.75 | |
| Obseva Sa | 0.0 | $199k | 83k | 2.41 | |
| Amarin Corporation (AMRN) | 0.0 | $159k | 40k | 4.00 | |
| Aeterna Zentaris | 0.0 | $60k | 117k | 0.51 | |
| Stealth Biotherapeutics Corp | 0.0 | $47k | 38k | 1.25 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $46k | 111k | 0.41 |
